Biocryst Pharmaceuticals (BCRX) EBT (2010 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly EBT came in at -$720.8 million in Q1 2026, down 95193.4% YoY from N/an in Q1 2025, and down 390.63% on a QoQ basis from $248.0 million in Q4 2025.
Biocryst Pharmaceuticals (BCRX) EBT (2010 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 17 years of EBT data on file, last reported at -$720.8 million in Q1 2026.
- Quarterly EBT fell 95193.4% year-over-year to -$720.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$454.2 million (down 787.37% YoY) and the FY2025 annual result came in at $267.4 million, up 407.51% from the prior year.
- EBT fell to -$720.8 million in Q1 2026, from $248.0 million in the prior quarter.
- In the past five years, EBT ranged from a high of $248.0 million in Q4 2025 to a low of -$720.8 million in Q1 2026.
- A 5-year average of -$59.5 million and a median of -$35.8 million in 2023 frame the typical range for EBT.
- Annual changes were most pronounced in 2025 — EBT surged 1054.24% — and 2026, when it slumped 95193.4%.
- Tracing BCRX's EBT over 5 years: stood at -$71.5 million in 2022, then grew by 11.62% to -$63.2 million in 2023, then jumped by 58.85% to -$26.0 million in 2024, then surged by 1054.24% to $248.0 million in 2025, then sank by 390.63% to -$720.8 million in 2026.
- The last three EBT figures came in at -$720.8 million (Q1 2026), $248.0 million (Q4 2025), and $12.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.10 Bn | 214.41 Mn | 79.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 79.47 Mn |
| Mar 31, 2026 | -720.81 Mn |
| Dec 31, 2025 | 248.02 Mn |
| Sep 30, 2025 | 12.13 Mn |
| Jun 30, 2025 | 6.49 Mn |
| Mar 31, 2025 | 758,000.00 |
| Dec 31, 2024 | -25.99 Mn |
| Sep 30, 2024 | -13.45 Mn |
| Jun 30, 2024 | -12.50 Mn |
| Mar 31, 2024 | -35.01 Mn |
| Dec 31, 2023 | -63.16 Mn |
| Sep 30, 2023 | -35.82 Mn |
| Jun 30, 2023 | -74.59 Mn |
| Mar 31, 2023 | -52.66 Mn |
| Dec 31, 2022 | -71.47 Mn |
| Sep 30, 2022 | -41.00 Mn |
| Jun 30, 2022 | -58.00 Mn |
| Mar 31, 2022 | -73.92 Mn |
| Dec 31, 2021 | -15.53 Mn |
| Sep 30, 2021 | -58.80 Mn |